TAG:
molecular diagnostic
Siemens Executive Speaks on Integration Strategies
CEO SUMMARY: Siemens has a vision of tight integration of in vitro and in vivo diagnostics with informatics to support a single goal with two themes: enhancing work flow in healthcare. Theme one is that …
New Technologies Bring New Issues for Pathologists
TECHNOLOGICAL IMPROVEMENTS ARE MOVING through the lab industry like a buzz saw through balsa. Three briefings in this issue provide examples. In two briefings, we address the topic of false positive results generated in part because of innovations in molecular testing. In the third briefing, we expla…
Whooping Cough Cases Reveal Test Deficiencies
CEO SUMMARY: Doctors rely on labs for the definitive diagnosis of the bacterium that causes whooping cough. Yet in several recent cases, the use of a molecular test for a definitive diagnosis led to questions about the effectiveness of the test. Molecular pathologists recommend labs may n…
New Rules to Boost Cancer Test Accuracy
CEO SUMMARY: Recent developments in breast cancer testing are leading to changes in pathology. Oncologists and pathologists have issued new guidelines regarding HER2 testing and new research suggests changes may be coming for estrogen-receptor testing as well. For the first time, the new …
IVD Stunner: GE to Acquire Abbott’s Diagnostics Unit
CEO SUMMARY: General Electric Corporation made a dramatic entrance into in vitro diagnostics (IVD) by acquiring almost all of Abbott Laboratories’ IVD business division. Once the sale is closed later this spring, GE will be the second major imaging vendor to buy its way into the IVD bus…
Key Trends Drive Change for Clinical Laboratories
CEO SUMMARY: Technology plays an ever-growing role in reshaping the organization and operation of clinical laboratories. New technologies figure prominently in THE DARK REPORT’S 2007 list of key trends in the clinical laboratory industry. Technological advances in instr…
2006’s Top Lab Stories Identify New Threats
CEO SUMMARY: Presented here are THE DARK REPORT’S “Ten Biggest Lab Stories of 2006.” Compared to earlier years, 2006 was not transformative for the laboratory industry. But it was an eventful year, particularly influenced by Siemens’ decision to acquire DPC and Bayer Diagnostics, …
December 18, 2006 “Intelligence: Late Breaking Lab News”
Last Friday, Luminex Corporation of Austin, Texas announced that it would acquire Tm Bioscience Corp. of Toronto, Ontario. Luminex will pay $44 million, which represents a 41.5% premium for Tm shares based on the December 14 closing price. Tm Bioscience has tests for DNA-based diagno…
November 6, 2006 “Intelligence: Late Breaking Lab News”
There’s regulatory relief for California labs in the important area of technical staff licensing. California’s Department of Health Services (DHS) has approved the Board of Registry medical technologist (MT) examination administered by the American Society of Clinical Pat…
Pathologists Contribute To Women’s Hospital
CEO SUMMARY: Speedier pathology reports and more active involvement with clinicians are two ways that the 15 pathologists at Pathology Group of the Mid-South help Baptist Memorial Women’s Hospital meet its goals of improved outcomes and a patient-friendly environment. Even with an off-s…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.